Literature DB >> 6660889

Management of thalassaemia major.

B Modell, M Petrou.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6660889      PMCID： PMC1628578          DOI： 10.1136/adc.58.12.1026

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  18 in total

1.  Total management of thalassaemia major.

Authors:  B Modell
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

2.  Continuous subcutaenous administration of deferoxamine in patients with iron overload.

Authors:  R D Propper; B Cooper; R R Rufo; A W Nienhuis; W F Anderson; H F Bunn; A Rosenthal; D G Nathan
Journal:  N Engl J Med       Date:  1977-08-25       Impact factor: 91.245

3.  Some effects of splenectomy in thalassaemia major.

Authors:  L M Blendis; C B Modell; A J Bowdler; R Williams
Journal:  Br J Haematol       Date:  1974-09       Impact factor: 6.998

4.  Prevention of thalassaemia in Cyprus.

Authors:  M A Angastiniotis; M G Hadjiminas
Journal:  Lancet       Date:  1981-02-14       Impact factor: 79.321

5.  Haemoglobin levels and blood requirement in thalassaemia.

Authors:  V Gabutti; A Piga; P Nicola; C Vullo; L Capra; A Di Palma; G Masera; S Terzoli; R Mauri
Journal:  Arch Dis Child       Date:  1982-02       Impact factor: 3.791

6.  New approaches to the transfusion management of thalassemia.

Authors:  R D Propper; L N Button; D G Nathan
Journal:  Blood       Date:  1980-01       Impact factor: 22.113

7.  Effect of introducing antenatal diagnosis on reproductive behaviour of families at risk for thalassaemia major.

Authors:  B Modell; R H Ward; D V Fairweather
Journal:  Br Med J       Date:  1980-06-07

8.  Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress.

Authors:  M Barry; D M Flynn; E A Letsky; R A Risdon
Journal:  Br Med J       Date:  1974-04-06

9.  Role of chronic hepatitis in development of thalassaemic liver disease.

Authors:  G Masera; G Jean; G Gazzola; M Novakova
Journal:  Arch Dis Child       Date:  1976-09       Impact factor: 3.791

10.  Iron absorption in the thalassemia syndromes and its inhibition by tea.

Authors:  P A de Alarcon; M E Donovan; G B Forbes; S A Landaw; J A Stockman
Journal:  N Engl J Med       Date:  1979-01-04       Impact factor: 91.245
View more
  4 in total

1.  Services for thalassaemia as a model for cost-benefit analysis of genetics services.

Authors:  B Modell; A M Kuliev
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Genetic screening for ethnic minorities.

Authors:  M Modell; B Modell
Journal:  BMJ       Date:  1990-06-30

3.  Cost-benefit analysis of a thalassemia disease prevention program.

Authors:  J T Ostrowsky; A Lippman; C R Scriver
Journal:  Am J Public Health       Date:  1985-07       Impact factor: 9.308

4.  Association of Iron Overload with Oxidative Stress, Hepatic Damage and Dyslipidemia in Transfusion-Dependent β-Thalassemia/HbE Patients.

Authors:  Chintana Sengsuk; Orathai Tangvarasittichai; Prasert Chantanaskulwong; Ampai Pimanprom; Somsak Wantaneeyawong; Anuchit Choowet; Surapon Tangvarasittichai
Journal:  Indian J Clin Biochem       Date:  2013-08-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.